Core Needle Biopsy Market: Insights, Key Players, and Growth Analysis 2021 –2028

rohansharma75data

posted on 2 hours ago — updated on 1 second ago

11
views

Rising cases of liver, prostate, breast and lung cancer have induced growth in the demand for core needle biopsy. Data Bridge Market Research analyses that the core needle biopsy will exhibit a CAGR of around 2.61% for the forecast period of 2021-2028.

The Core Needle Biopsy Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2028. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Brief Overview of the Core Needle Biopsy Market:

The global Core Needle Biopsy Market is expected to experience substantial growth between 2024 and 2028. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-core-needle-biopsy-market

Which are the top companies operating in the Core Needle Biopsy Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Core Needle Biopsy Market report provides the information of the Top Companies in Core Needle Biopsy Market in the market their business strategy, financial situation etc.

BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD.

Report Scope and Market Segmentation

Which are the driving factors of the Core Needle Biopsy Market?

The driving factors of the Core Needle Biopsy Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Core Needle Biopsy Market - Competitive and Segmentation Analysis:

**Segments**

- **Product Type:** The core needle biopsy market can be segmented into fine-needle aspiration biopsy and core needle biopsy. Core needle biopsy is expected to witness substantial growth due to higher accuracy rates and minimally invasive nature, leading to increased adoption by healthcare providers and patients.

- **End-User:** The market can also be segmented by end-users, including hospitals, diagnostic centers, oncology centers, and research institutes. The increasing incidence of cancer cases worldwide is driving the demand for core needle biopsy procedures in hospitals and diagnostic centers, contributing significantly to market growth.

- **Application:** Core needle biopsies are widely utilized in diagnosing breast cancer, lung cancer, prostate cancer, and other types of cancer. The growing prevalence of cancer across various demographics is expected to boost the demand for core needle biopsies in the forecast period.

**Market Players**

- **BD**
- **Argon Medical Devices, Inc.**
- **C. R. Bard, Inc.**
- **Cook Medical**
- **Hologic, Inc.**
- **Medtronic**
- **Braun Melsungen AG**
- **R. Bard, Inc.**
- **Boston Scientific Corporation**
- **Merit Medical Systems**
- **Innomostics LLC**

The global core needle biopsy market is anticipated to witness significant growth by 2028, driven by factors such as the rising prevalence of cancer cases, technological advancements in biopsy procedures, and increasing awareness about early disease detection. Core needle biopsy offers higher precision in diagnosing various types of cancer, leading to its widespread adoption by healthcare professionals. The market segmentation based on product type, end-users, and applications provides insights into the diverse dynamics fueling market expansion. Fine-needle aspiration biopsy and core needle biopsy are crucial segments expected to drive market growth. The increasing utilization of core needle biopsy in hospitals, diagnostic centers, and oncology centers showcases the demand for improved diagnostic techniques to combat cancer effectively. Moreover, the application ofThe global core needle biopsy market is a dynamic landscape driven by the increasing incidence of cancer cases globally. As cancer continues to be a significant health concern, the demand for accurate and minimally invasive diagnostic procedures like core needle biopsy is on the rise. This market segment is poised for significant growth, with key players like BD, Argon Medical Devices, Inc., and Cook Medical leading the way in innovation and technology advancements. These companies are focused on developing state-of-the-art biopsy devices that offer high precision and reliability in cancer diagnosis.

One of the critical segments within the core needle biopsy market is the product type classification, distinguishing between fine-needle aspiration biopsy and core needle biopsy. Core needle biopsy is gaining traction due to its higher accuracy rates, making it a preferred choice for healthcare providers and patients. The minimally invasive nature of core needle biopsy procedures also contributes to its increasing adoption, driving market growth. This segment is expected to witness substantial expansion in the coming years as the demand for more efficient and reliable diagnostic tools grows.

End-user segmentation is another crucial aspect of the core needle biopsy market, with hospitals, diagnostic centers, oncology centers, and research institutes playing a vital role in driving market demand. The rising number of cancer cases necessitates the use of core needle biopsy procedures in hospitals and diagnostic centers, where early detection and accurate diagnosis are paramount. These end-users are at the forefront of advancing cancer diagnosis and treatment, creating a robust market ecosystem for core needle biopsy devices and services.

The application segment further amplifies the market dynamics by highlighting the diverse uses of core needle biopsies in diagnosing various types of cancer such as breast cancer, lung cancer, and prostate cancer. With the increasing prevalence of cancer across different demographics, the demand for core needle biopsy procedures is expected to surge in the forecast period. Oncology centers and research institutes are instrumental in driving innovation and advancements in core needle biopsy applications, contributing to market growth and expansion.

In conclusion, the global core needle biopsy market is set for significant**Market Players**
- BD
- Hologic, Inc.
- Devicor Medical Products, Inc.
- ARGON MEDICAL.
- SOMATEX Medical Technologies GmbH
- INVIVO THERAPEUTICS
- MDL SRL.
- STERYLAB S.r.l.
- UROMED Kurt Drews KG
- BPB medica
- Koninklijke Philips N.V.
- Medtronic
- GENERAL ELECTRIC COMPANY
- Leica Biosystems Nussloch GmbH
- ZAMAR CARE.
- Stryker
- Messe Düsseldorf GmbH
- Kompass
- COMPASS International Innovations, Inc.
- HAKKO CO.,LTD.

The global core needle biopsy market is experiencing substantial growth, driven by factors such as increasing cancer prevalence, technological advancements in biopsy procedures, and a growing emphasis on early disease detection. With key players like BD and Hologic, Inc. leading the market, there is a focus on innovation and development of high-precision biopsy devices to cater to the rising demand for accurate cancer diagnosis. The segmentation of the market based on product type, end-users, and applications provides a comprehensive understanding of the market landscape and the factors fueling its expansion.

Product type segmentation, distinguishing between fine-needle aspiration biopsy and core needle biopsy, highlights the growing preference for core needle biopsy due to its higher accuracy rates and minimally invasive nature. This segment is expected to witness significant growth as healthcare providers and patients lean

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Core Needle Biopsy Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global Core Needle Biopsy Market, expected to exhibit impressive growth in CAGR from 2024 to 2028.

Explore Further Details about This Research Core Needle Biopsy Market Report https://www.databridgemarketresearch.com/reports/global-core-needle-biopsy-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Core Needle Biopsy Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Core Needle Biopsy Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Core Needle Biopsy Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2028) of the following regions are covered in Chapters

The countries covered in the Core Needle Biopsy Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Core Needle Biopsy Market Insights and Forecast to 2028

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Core Needle Biopsy Market Landscape

Part 05: Pipeline Analysis

Part 06: Core Needle Biopsy Market Sizing

Part 07: Five Forces Analysis

Part 08: Core Needle Biopsy Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Core Needle Biopsy Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com